Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
- PMID: 32459046
- PMCID: PMC7283841
- DOI: 10.1111/jth.14929
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Keywords: SARS-CoV-2; anticoagulant; antithrombotic therapy; coronavirus disease 2019; hospitalization.
Comment in
-
Three-month follow-up of pulmonary embolism in patients with COVID-19.Thromb Res. 2021 May;201:113-115. doi: 10.1016/j.thromres.2021.02.023. Epub 2021 Feb 26. Thromb Res. 2021. PMID: 33662797 Free PMC article. No abstract available.
References
-
- Novel Coronavirus (2019‐nCoV) situation reports n.d. https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/situatio.... (Accessed March 17, 2020).
-
- Obi A.T., Tignanelli C.J., Jacobs B.N., et al. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317–324. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
